Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil

Journal of Clinical Oncology

Volumn 14, Issue 6, 1996, Pages 1818-1828

  Kelsen, D ^a   Karpeh, M ^a   Schwartz, G ^a   Gerdes, H ^a   Lightdale, C ^a   Botet, J ^a   Lauers, G ^a   Klimstra, D ^a   Huang, Y ^a   Saltz, L ^a   Quan, V ^a   Brennan, M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DRUG FATALITY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENCE RISK; STOMACH CANCER;

EID: 8944230186     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.6.1818     Document Type: Article

References (38)

1. Alexander HR, Kelsen DP, Tepper JE: Cancer of the stomach, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott, 1993, pp 818-848
2. Blot WJ, Devesa SS, Kneller RW, et al: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287-1289, 1991
3. McNeer G, Vanderberg H, Donn F, et al: A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach. Ann Surg 134:1-7, 1951
4. Gunderson LL, Sosin H: Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1-11, 1982
5. Reiss M, Sartorelli AC: Transforming growth factor beta (TGFBETA) induces differentiation of cultured human squamous cell carcinomas (SQCCS) in the presence of epidermal growth factor (EGF) (meeting abstract). Proc Am Assoc Cancer Res 27:227, 1986 (abstr)
6. Smith JW, Brennan MF, Botet JF, et al: Preoperative endoscopic ultrasound can predict the risk of recurrence after operation for gastric carcinoma. J Clin Oncol 11:2380-2385, 1993
7. Botet JF, Lightdale CJ, Zauber AG, et al: Preoperative staging of gastric cancer: Comparison of endoscopie US and dynamic CT (see comments). Radiology 181:426-432, 1991
8. Lightdale C, Botet J, Brennan M, et al: Endoscopic ultrasonography compared to computerized tomography for preoperative staging of gastric cancer. Gastrointest Endosc 35:154-159, 1989
9. Nattermann C, Dancygier H: Endosonography of stomach tumors (in German). Leber Magen Darm 22:211-219, 1992
10. Grimm H, Soehendra N, Hamper K, et al: Contribution of endosonography to preoperative staging in esophageal and stomach cancer (in German). Chirurg 60:684-689, 1989
11. Machi J, Takeda J, Kakegawa T, et al: The detection of gastric and esophageal tumor extension by high-resolution ultrasound during surgery. World J Surg 11:664-671, 1987
12. Kelsen D, Atiq OT, Saltz L, et al: FAMTX versus etoposide, doxorubicin, and cisplatin: A random assignment trial in gastric cancer. J Clin Oncol 10:541-548, 1992
13. Atiq OT, Kelsen DP, Shiu MH, et al: Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. J Clin Oncol 11:425-433, 1993
14. Wils J, Bleiberg H, Dalesio O, et al: An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with Adriamycin in advanced measurable gastric cancer. J Clin Oncol 4:1799-1803, 1986
15. Wils JA, Klein HO, Wagener DJ, et al: Sequential high-dose methotrexate and fluorouracil combined with doxorubicin - A step ahead in the treatment of advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 9:827-831, 1991
16. Christman K, Saltz L, Schwartz G, et al: Granulocyte colony-stimulating factor: Effective in ameliorating fluorouracil-based myelosuppression? J Natl Cancer Inst 85:826-827, 1993
17. Kelsen D, Gerdes H, Schwartz G, et al: Endoscopic ultrasonograpy (EUS) as a measure of response to chemotherapy of gastric cancer. Proc Am Soc Clin Oncol 12:196, 1993 (abstr)
18. Klein HO: Long-term results with FAMTX (5-fluorouracil, Adriamycin, methotrexate) in advanced gastric cancer. Anticancer Res 9:1025-1026, 1989
19. Klein HO, Wickramanayake PD, Dieterle F, et al: Chemotherapy schedule for the management of metastasizing gastric cancer. Methotrexate, Adriamycin and 5-fluorouracil (in German) Deutsche Med Wochenschr 107:1708-1712, 1982
20. Heberer G, Teichmann RK, Kramling HJ, et al: Results of gastric resection for carcinoma of the stomach: The European experience. World J Surg 12:374-381, 1988
21. Haugstvedt TK, Viste A, Eide GE, et al: Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. The Norwegian Stomach Cancer Trial. Br J Surg 80:475-478, 1993
22. Roder JD, Bottcher K, Siewert JR, et al: Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 72:2089-2097, 1993
23. Wanebo H, Kennedy BJ, Chmiel J, et al: Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218:583-592, 1993
24. Serlin O, Wolkoff J, Amandeo J, et al: Use of 5-fluorodeoxyuridine as an adjuvant to the surgical management of carcinoma of the stomach. Cancer 25:223-228, 1969
25. Engstrom PF, Lavin PT, Douglass HO Jr, et al: Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275). Cancer 55:1868-1873, 1985
26. Higgins GA, Amadeo JH, Smith DE, et al: Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology Group report. Cancer 52:1105-1112, 1983
27. Coombes RC, Schein PS, Chilvers CE, et al: A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group. J Clin Oncol 8:1362-1369, 1990
28. Nakajima T, Takahashi T, Takagi K, et al: Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J Clin Oncol 2:1366-1371, 1984
29. Ochiai T, Sato H, Hayashi R, et al: Randomly controlled study of chemotherapy versus chemoimmunotherapy in postoperative gastric cancer patients. Cancer Res 43:3001-3007, 1983
30. Hermans J, Bonenkamp JJ, Boon MC, et al: Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 11:1441-1447, 1993
31. Dent D, Werner I, Novis B, et al: Prospective randomized trial of combined oncological therapy for gastric carcinoma. Cancer 44:385-391, 1979
32. Moertel CG, Childs DS, O'Fallon JR, et al: Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol 2:1249-1254, 1984
33. Hagiwara A, Takahashi T, Kojima O, et al: Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339:629-631, 1992
34. Wilke H, Preusser P, Fink U, et al: Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: A phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7:1318-1326, 1989
35. Ajani JA, Ota DM, Jessup JM, et al: Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer 68:1501-1506, 1991
36. Leichman L, Silberman H, Leichman CG, et al: Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: A University of Southern California pilot program. J Clin Oncol 10:1933-1942, 1992
37. Harris JR, Morrow M, Bonadonna G: Cancer of the breast, in DeVita VT Jr, Hellman S, Rosenberg SA: Cancer Principles and Practice of Oncology. Philadelphia, PA, Lippincott, 1993, pp 1264-1332
38. Kelsen D, Saltz L, Cohen A, et al: A phase I trial of immediate postopertive intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole following resection of high-risk colon cancer. Cancer 74:2224-2233, 1994